GE Healthcare Barges into Cell-Therapy Arena with Swiss Buy; Where’s the FDA?
GE Healthcare (Little Chalfont GBR) just signaled its intention to build a $1 billion business which offers specialized manufacturing tools for an upcoming tidal wave of cell therapies by acquiring… Read more »